Overview

Study of STA-1 Capsule in Patients With Vascular Dementia (Marrow-Sea Deficiency)

Status:
Completed
Trial end date:
2002-10-01
Target enrollment:
Participant gender:
Summary
The objectives of this phase II study of STA-1 capsule was to make preliminary evaluation on clinical efficacy and safety of STA-1 capsule in order that based on the dosage and study structure planned in this project, the dosage and study structure of phase III study can be confirmed.
Phase:
Phase 2
Details
Lead Sponsor:
Sinphar Pharmaceutical Co., Ltd
Treatments:
Dihydroergotoxine
Ergoloid Mesylates